ArticlePloS one2019

Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.

Attila Tordai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.